<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859629</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1667</article-id><article-id pub-id-type="other">EPV1095</article-id><article-id pub-id-type="pii">S0924933824016675</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Are we braver today in using antidepressants perinatally?- own clinical experiences</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mati&#x00107;</surname><given-names>K.</given-names></name><xref rid="aff3603" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Vuk Pisk</surname><given-names>S.</given-names></name><xref rid="aff3603" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3604" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1512" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ivezi&#x00107;</surname><given-names>E.</given-names></name><xref rid="aff3603" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3605" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gro&#x00161;i&#x00107;</surname><given-names>V.</given-names></name><xref rid="aff3603" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3604" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Filip&#x0010d;i&#x00107;</surname><given-names>I.</given-names></name><xref rid="aff3603" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3605" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff3606" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="aff3603"><sup>1</sup><institution>University Psychiatric Clinic Sveti Ivan</institution>, <city>Zagreb</city></aff><aff id="aff3604"><sup>2</sup><institution>Faculty of Dental Medicine and Health</institution>, <city>Osijek</city></aff><aff id="aff3605">
<sup>3</sup>
<institution>Faculty of Dental Medicine and Health</institution>
</aff><aff id="aff3606"><sup>4</sup><institution>University of Zagreb School of medicine</institution>, <city>Zagreb</city>, <country>Croatia</country></aff><author-notes><corresp id="cor1512"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1642">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S800</fpage><lpage>S800</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824016675a.pdf"/><abstract><sec id="sec9088"><title>Introduction</title><p>
Affective disorders are among the most common mental health problems in women of reproductive age. A life-changing condition, such as pregnancy, may trigger or intensify symptoms of affective disorders, rather than pregnancy being a protective factor for the development of the disorder, as previously thought. Previous research indicates that 18% of women suffer from perinatal depression. One in 7-10 pregnant women and 1 in 5-8 midwives develops a depressive disorder, which is more than half a million women a year. Untreated perinatal depression has significant repercussions for both mother and child. Given that there are no controlled randomized studies during pregnancy, and the results of previous research on the harmfulness of the use of psychotropic drugs are contradictory, we need to nurture an individualized and integrative approach to the use of psychotropic drugs in pregnant women and in the postpartum period. The goal of this lecture is to point out the necessity of treating perinatal depressive disorder with an emphasis on the need to work on dilemmas and selected sources of information by pregnant women themselves, as well as health professionals. In the end, I must emphasize the importance of choosing an adequate psychopharmaceutical in that sensitive period for a woman, nurturing an individual approach as well as the latest knowledge.</p></sec><sec id="sec9089"><title>Objectives</title><p>The aim of this research is to examine the attitudes of psychiatrists, GP doctors, gynecologists and pregnant women about prescribing and taking pharmacotherapy during pregnancy.</p></sec><sec id="sec9090"><title>Methods</title><p>The research will be conducted at the psychiatry clinic, the gynecology clinic and in health centers through semi-structured questionnaires, which will be filled out by psychiatrists, gynecologists, doctors and pregnant women.</p></sec><sec id="sec9091"><title>Results</title><p>Preliminary results (given that the research is still ongoing) indicate that most psychiatrists avoid prescribing drugs during pregnancy, and if they decide to do so, then diazepam is prescribed. The views of gynecologists, family medicine doctors and pregnant women are still pending.</p></sec><sec id="sec9092"><title>Conclusions</title><p>This lecture aims to point out the factors contributing to the fear of prescribing psychotropic drugs perinatally, based on our own research, which included psychiatrists, gynecologists, family medicine doctors, and pregnant women.</p></sec><sec id="sec9093"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>